Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Plos One|May 24, 2024
Optimal timing of a colonoscopy screening schedule depends on adenoma detection, adenoma risk, adherence to screening and the screening objective: A microsimulation studyViktor Zaika, Meher K Prakash, Chih-Yuan Cheng, et al.
Frontiers in Public Health|February 28, 2022
The COVID-19 Pandemic and Cancer Patients in Germany: Impact on Treatment, Follow-Up Care and Psychological BurdenRachel D Eckford, Andrea Gaisser, Volker Arndt, et al.
Journal of Market Access & Health Policy|November 19, 2016
Determining the value of medical technologies to treat ultra-rare disorders: a consensus statementMichael Schlander, Silvio Garattini, Peter Kolominsky-Rabas, et al.
International Journal of Cancer|July 16, 2025
Cost effectiveness analysis of prostate cancer screening strategies in Germany: A microsimulation studyMuchandifunga Trust Muchadeyi, Shuang Hao, Karla Hernandez-Villafuerte, et al.
International Journal of Health Policy and Management|August 24, 2019
Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case StudyMonika Wagner, Dima Samaha, Roman Casciano, et al.
Pharmacoeconomics|March 29, 2024
Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual ConsiderationsMuchandifunga Trust Muchadeyi, Karla Hernandez-Villafuerte, Gian Luca Di Tanna, et al.
Journal of Comparative Effectiveness Research|October 3, 2014
Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disordersMichael Schlander, Silvio Garattini, Søren Holm, et al.
Gastrointestinal Endoscopy|February 18, 2021
Evaluating key characteristics of ideal colorectal cancer screening modalities: the microsimulation approachAnsgar Deibel, Lu Deng, Chih-Yuan Cheng, et al.
Journal of Cancer Research and Clinical Oncology|October 13, 2021
Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based studyMelissa S Y Thong, Daniela Doege, Linda Weißer, et al.
Orphanet Journal of Rare Diseases|March 12, 2017
Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL)Lieven Annemans, Ségolène Aymé, Yann Le Cam, et al.
Pageof 7